Estadístiques de The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.

Visites totals

views
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer. 410

Visites totals per mes

views
October 2024 0
November 2024 1
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

Visites al fitxer

views
sanchez-ccr-thef.pdf(legacy) 340
sanchez-ccr-thef.pdf 35

Vistes principals per país

views
United States 284
France 25
Spain 20
Ireland 18
Sweden 16
Germany 12
China 7
Brazil 5
United Kingdom 5
Belgium 4
Italy 4
Canada 2
Russia 2
Ukraine 2
Czechia 1
Latvia 1
Macedonia 1
Malaysia 1

Visites principals per ciutat

views
Ashburn 84
Fairfield 47
Mountain View 19
Dublin 18
San Ramon 17
Cambridge 13
Barcelona 9
Boardman 8
Sunnyvale 7
Seattle 6
Ann Arbor 5
Beijing 5
Menlo Park 5
San Diego 5
Fremont 4
Montréal 2
Redwood City 2
Rezé 2
Salamanca 2
San Juan De Alicante 2
Shenzhen 2
Tustin 2
Andover 1
Bitola 1
Chandler 1
Des Moines 1
Falls Church 1
Indiana 1
Irvine 1
Jacksonville 1
Lancaster 1
Layos 1
Magdeburg 1
Milan 1
Nantes 1
Phoenix 1
Raritan 1
Shah Alam 1
Wilmington 1
Woodbridge 1